Cognitive & Neuropeptides
Nootropic and neuroprotective research peptides from the Russian academic tradition. Selank (TP-7) as a Tuftsin analogue for studies on anxiolysis and immune modulation, Semax as an ACTH fragment 4-10 for research on BDNF/NGF expression and cognitive resilience, plus the popular Semax-Selank combination. All three have been studied since the 1990s at the Institute of Molecular Genetics (RAS) in Moscow and are clinically approved in Russia, while remaining research compounds in the West. Every batch is HPLC-tested with a batch-specific CoA from Janoshik Analytical.
All products
Related research
April 17, 2026
Selank vs. Benzodiazepines: The Science-Backed Alternative for Anxiety Research
Selank vs. benzodiazepines compared: Zozulia 2008 RCT vs. medazepam, GABA-A modulation without sedation, no dependence. What Russian anxiolytic research shows.
Read more →
April 17, 2026
Semax and Alzheimer's: What the 2025 Amyloid Plaque Study Means
Acta Naturae 2025 (Radchenko et al.): Intranasal Semax reduces amyloid plaques 2.8-fold cortical and 2.6-fold hippocampal in an Alzheimer mouse model.
Read more →
March 22, 2026
Buy Selank: Anxiolytic Peptide for Neuroscience Research
Buy research-grade Selank peptide (Tuftsin derivative). Janoshik-verified, EU shipping in 2-3 days. GABA modulation, anxiolytic effects and research.
Read more →


